Disclaimer: This is an early beta prototype. If you find any error, with data or functionality, please let us know via this page.
Registration date period
Results ordered by trial registration date, descending.
  1. Circulating Tumor DNA in Patients at High Risk for Lung Cancer

    Registration date:
    Status:
    Ongoing
    Recruitment status:
    Recruiting
    Source name:
    ClinicalTrials.gov

    Patients who are about to undergo a diagnostic or therapeutic bronchoscopy or thoracic surgery without a distant history of cancer will have their blood drawn for measurement of ...

    Conditions:
    • adenocarcinoma of the lung
    • Lung Neoplasms
    • Lung cancer
    • Non Small Cell Carcinoma of the Lung
    • Cancer of the Lung
    • Small Cell Carcinoma of the Lung
    Interventions:

    Unknown

  2. Plasma ctDNA in Patients Undergoing Diagnostic Colonoscopy

    Registration date:
    Status:
    Ongoing
    Recruitment status:
    Not recruiting
    Source name:
    ClinicalTrials.gov

    When the DNA inside of human cells undergoes certain alterations (mutations), the cells may develop into a cancer. The cancer cells may shed this DNA into the blood stream. This ...

    Conditions:
    • Colon Polyps
    • Colon Adenomas
    • colon cancer
    Interventions:

    Unknown

  3. A Pilot Surveillance Study to Monitor Natural Killer Cells and Circulating Tumor Cells in Women With Previously Treated Non-metastatic Triple Negative Breast Cancer and Women With Previously Treated Non-metastatic Breast Cancer With a Confirmed BRCA Mutation

    Registration date:
    Status:
    Ongoing
    Recruitment status:
    Not recruiting
    Source name:
    ClinicalTrials.gov

    The purpose of this research study is: - To test blood for the presence of tumor derived circulating tumor cells (CTCs) or circulating tumor DNA (ctDNA) using an investigational...

    Conditions:
    • Triple Negative Breast Cancer
    • Natural Killer Cells
    • BRCA Mutation
    Interventions:
    • LiquidBiopsy®, NK VueTM
  4. EGFR Mutations on ctDNA in Patients With Advanced NSCLC

    Registration date:
    Status:
    Ongoing
    Recruitment status:
    Recruiting
    Source name:
    ClinicalTrials.gov

    The study aims to explore the prevalence of EGFR mutations assessed with ctDNA samples in advanced NSCLC, who had received ≤ 1 prior systemic chemotherapy regimens.

    Conditions:
    • Non-small Cell Lung Cancer Metastatic
    • Non-small cell lung cancer, stage III
    Interventions:
    • mutation detection
    • ctDNA analysis
    • ARMS
  5. Concordance Between ctDNA Assay and FoundationOne

    Registration date:
    Status:
    Ongoing
    Recruitment status:
    Recruiting
    Source name:
    ClinicalTrials.gov

    Foundation Medicine Inc. (FMI) is interested in studying the concordance of genomic alterations between primary and/or metastatic surgical biopsies, and circulating tumor DNA (ctDNA)...

    Conditions:
    • Genomic Testing
    • Genomic Alterations
    • Cancer
    • Neoplasms
    • Circulating Tumor DNA
    Interventions:

    Unknown